Indaptus Therapeutics, Inc. (INDP) Financials
INDP Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 12.0 million | 615426 |
| March 31, 2026 | 2.2 million | 932999 |
| Dec. 31, 2025 | 9.3 million | 6.2 million |
| Sept. 30, 2025 | 6.8 million | 2.2 million |
INDP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -1.9 million | -64283 |
| March 31, 2026 | -7.0 million | 227180 |
| Dec. 31, 2025 | -3.2 million | 785814 |
| Sept. 30, 2025 | -3.1 million | 150614 |
INDP Net Income
No data available :(
INDP Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 11.6 million | - | - |
| March 31, 2026 | 1.5 million | - | - |
| Dec. 31, 2025 | 8.5 million | - | - |
| Sept. 30, 2025 | 5.8 million | - | 8686 |
INDP Shares Outstanding
INDP Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 363127 | 1.4 million | - |
| March 31, 2026 | 3 | 491134 | 1.7 million | - |
| Dec. 31, 2025 | - | 2.8 million | 5.3 million | - |
| Sept. 30, 2025 | 2 | 1.5 million | 1.1 million | - |
INDP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | - | - |
INDP
Price: $2.77
52 week price:
Earnings Per Share: -3.36 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 19752
Market Capitalization: 138.2 million